Articles in section Mergers & Acquisitions

<< Licensing

613 articles

Opinion & Analysis >>

Pages 1 2 3 4 5 .. 62

Next >>

Bristol Myers Squibb Buys Turning Point for US$4.1 B Published: 8 Jun-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 6
GlaxoSmithKline Acquires Affinivax for US$3.3 B Published: 3 Jun-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 6
Pfizer Buys Biohaven for US$11.6 B Published: 13 May-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 5
Caladrius and Cend Merge to Become Lisata Therapeutics Published: 30 Apr-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 4
Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition Published: 21 Apr-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 4
GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout Published: 21 Apr-2022
By: Sasha Yachu
Abstract Fulltext:
Volume: 2022 Issue: 4
Pfizer Bolsters RSV Pipeline with US$525 M ReViral Acquisition Published: 15 Apr-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 4
Biocon Biologics Acquires Viatris’ Biosimilar Portfolio for US$3.3 B Published: 2 Mar-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 3
Equillium Acquires Bioniz Therapeutics to Strengthen Immunology Portfolio Published: 23 Feb-2022
By: Ayush Saxena & Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 2
UCB Acquires Zogenix to Bolster its Epilepsy Portfolio Published: 1 Feb-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 2

Login

Username:

Password:

Keep me logged in